IPOL - 49281-860-10 - (POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED))

Alphabetical Index


Drug Information of IPOL

Product NDC: 49281-860
Proprietary Name: IPOL
Non Proprietary Name: POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Active Ingredient(s): 40; 8; 32    [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL & nbsp;   POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of IPOL

Product NDC: 49281-860
Labeler Name: Sanofi Pasteur Inc.
Product Type: VACCINE
FDA Application Number: BLA103930
Marketing Category: BLA
Start Marketing Date: 19901221

Package Information of IPOL

Package NDC: 49281-860-10
Package Description: 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-860-10) > 5 mL in 1 VIAL, MULTI-DOSE

NDC Information of IPOL

NDC Code 49281-860-10
Proprietary Name IPOL
Package Description 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-860-10) > 5 mL in 1 VIAL, MULTI-DOSE
Product NDC 49281-860
Product Type Name VACCINE
Non Proprietary Name POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR
Start Marketing Date 19901221
Marketing Category Name BLA
Labeler Name Sanofi Pasteur Inc.
Substance Name POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Strength Number 40; 8; 32
Strength Unit [D'ag'U]/.5mL; [D'ag'U]/.5mL; [D'ag'U]/.5mL
Pharmaceutical Classes Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccine [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccine [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Poliovirus Vaccine [EPC],Actively Acquired Immunity [PE],Poliovirus Vaccine [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of IPOL


General Information